
The more than 43,000 volunteers in six countries who participated in the clinical trials of Pfizer’s vaccine candidate reported that it left them feeling hungover. On Monday, the pharmaceutical giant announced that its vaccine was more than 90% effective in preventing COVID-19 and will pursue emergency use approval by the Food and Drug Administration.















